SLC6A14 has been shown to be such a cancer-specific amino acid transporter: it is highly expressed in estrogen receptor-positive (ER+) breast cancers and pancreatic cancer, but low in normal tissues [21]. This evidence concerns the gene ESR1 and breast cancer.